Zosano Pharma Corp Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
Zosano Pharma Corp reported Net Income (Loss), Including Portion Attributable to Noncontrolling Interest of -$25.27 million for the 9-month period ending 2020-09-30, per its 10-Q filed 2020-11-13.
Discontinued › Income Statement › Net Income
us-gaap:ProfitLoss · last filed 2020-11-13
- Zosano Pharma Corp net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2020-09-30 was -$8.69M.
- Zosano Pharma Corp net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2020-06-30 was -$7.89M.
- Zosano Pharma Corp net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2020-03-31 was -$8.69M.
- Zosano Pharma Corp net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2019-09-30 was -$9.86M.
| Period end | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 3 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 6 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 9 month |
|---|---|---|---|
| 2020-09-30 | -$8.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | -$16.58M derived: sum of 2 quarters · filed 2020-11-13 | -$25.27M 10-Q · filed 2020-11-13 |
| 2020-06-30 | -$7.89M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | -$16.58M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | -$8.69M 10-Q · filed 2020-05-14 | ||
| 2019-09-30 | -$9.86M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | -$19.22M derived: sum of 2 quarters · filed 2020-11-13 | -$28.65M 10-Q · filed 2020-11-13 |
| 2019-06-30 | -$9.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | -$18.79M 10-Q · filed 2020-08-06 | |
| 2019-03-31 | -$9.43M 10-Q · filed 2020-05-14 | ||
| 2018-09-30 | -$8.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | -$17.00M derived: sum of 2 quarters · filed 2019-11-14 | -$25.21M 10-Q · filed 2019-11-14 |
| 2018-06-30 | -$8.84M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | -$17.04M 10-Q · filed 2019-08-14 | |
| 2018-03-31 | -$8.21M 10-Q · filed 2019-05-14 | ||
| 2017-09-30 | -$7.87M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-15 | -$21.62M 10-Q · filed 2018-11-15 | |
| 2017-06-30 | -$13.74M 10-Q · filed 2018-08-09 |